Casticin downregulated uPAR and CD33, upregulated AMPK and ACC and silenced FOXO3 expression through the AMPK/FOXO3 signaling pathway in small-cell lung cancer (SCLC) H446 cells [88]. This evidence concerns the gene CD33 and small cell lung carcinoma.